
Pfizer Reaches Deal On Most-Favored Nation Drug Pricing; Other Pharmas Expected To Follow
Newly launched Pfizer drugs will be priced at parity to prices in comparable developed nations, according to the most-favored nation pricing agreement.
Newly launched Pfizer drugs will be priced at parity to prices in comparable developed nations, according to the most-favored nation pricing agreement.
Leaders from the VA and the ONC discussed how the future of U.S. healthcare will rely on both technology and creative problem-solving during a panel at DiMe’s Healthcare 2030 Summit.
The future of business is here, and it's powered by QuickBooks.
A federal judge in Texas recently ruled on medical debt reporting — here's what the ruling means for providers and for those who have medical debt.
Employers expect costs to continue to rise, prompting a shift toward cost-containment, vendor accountability, AI adoption, and alternative plan designs.
Without strong guardrails, errors could have life-or-death consequences, said Lily Li, founder of law firm Metaverse Law.
During the MedCity INVEST Digital Health conference in Dallas, three executives shared what’s top of mind as they deploy AI in the healthcare workforce, including the need to build trust and improve interoperability.
Getting paid can be an arduous task. You should make it as easy on yourself and your clients as possible.
During a panel discussion at the MedCity INVEST Digital Health conference, investors shared what they're looking for from AI startups and what their red flags are.
Healthcare groups are pushing back on CMS’ proposed physician fee schedule for next year, raising concerns over payment cuts, administrative burdens and mandatory participation in a new value-based model.
Walgreens has completed its sale to private equity firm Sycamore Partners, raising concerns that the deal could lead to widespread store closures, layoffs, and reduced access to healthcare in vulnerable communities.
The latest episode of the Debunked podcast explores an ongoing debate questioning the role of payers in healthcare transactions. It also highlights turmoil at the CDC.
Adoption of Chrometa represents more than a technological upgrade; it reflects a professional philosophy that values accuracy, transparency, and efficiency.
The case centers on Epic’s alleged use of its influence over the Carequality data exchange to block Particle’s access to patient records and stifle competition in the emerging payer platform market.
If you're interested in health law, you need to see this list.
This marks a legal victory for Democrats and healthcare advocates who argued the rule would cause widespread coverage losses and violated federal law.
Florida plans to end all vaccine mandates, drawing sharp criticism from health experts who warn it threatens public health and could lead to preventable disease outbreaks.
They highlighted the technology’s potential to reduce administrative burdens and boost care access in rural areas — while also warning about oversight gaps and the risks of AI-driven prior authorization.